Testing Argus 2.0 CGM for diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study asks people with diabetes to wear three continuous glucose monitors (CGMs) for up to 15 days to compare how well they work. It tests a new CGM system called Argus 2.0, and you need to use your own smartphone for the study app.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have type 1 diabetes, type 2 diabetes, or prediabetes.
- You are willing to wear up to three continuous glucose monitors on your body for up to 15 days.
- You have a personal smartphone (iPhone or Android) with Bluetooth that you can use for the study app.
- You do not have any skin problems on your wrists, such as cuts, rashes, or tattoos.
- You are not pregnant, breastfeeding, or have certain heart conditions or cancer (except minor skin cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks you to wear a glucose monitor and smart ring for several months to help researchers understand how blood sugar changes throughout the day in people with prediabetes or type 2 diabetes. The goal is to learn how lifestyle and medications affect blood sugar control.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This study tests whether a continuous glucose monitor (CGM) can help people with prediabetes track their blood sugar levels over 20 days. You may be eligible if you have prediabetes, a BMI of 25 or higher, and a compatible smartphone.
This study tests whether using a smartphone app and a wearable device (like a fitness tracker), along with artificial intelligence (AI), can help people with type 2 diabetes better manage their condition and prevent complications. You would need to provide lifestyle information and use the devices for 3 months.
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
This study tests the ROME GS System, a glucose monitoring device that measures blood sugar levels. The system includes a sensor placed under the skin and a transmitter worn on the body. If you have diabetes and want to help evaluate a new way to track your blood sugar, this trial may be for you.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.